Espumisan baby drops for oral administration, 50ml

- symptoms of intestinal colic in infants;

- symptoms of excessive formation and accumulation of gases in the gastrointestinal tract (including flatulence, increased gas production in the postoperative period);

- symptoms of excessive gas formation caused by functional dyspepsia;

- preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (ultrasound, radiography, esophagogastroduodenoscopy, etc.), including, as an additive to contrast media suspensions for obtaining images by the double contrast method;

- acute poisoning with detergents containing foaming agents (tensides) as an antifoam agent.

Inside. Shake the bottle with the emulsion before use. The drug can be dispensed in drops, holding the bottle vertically with the opening down. For convenience, it can also be dispensed in milliliters using the measuring cap.

The drug is taken before / during or after each meal and, if necessary, before bedtime.

The frequency of admission and the duration of use depend on the severity of the symptoms.
If necessary, EspumisanЃ baby can be taken for a long time.

For complaints associated with infant colic and excessive gas production
Children under 1 year of age: 5-10 drops of EspumisanЃ baby (add to a bottle with baby food or give with a small spoon before / during or after feeding).
Children from 1 to 6 years old: 10 drops of EspumisanЃ baby 3-5 times a day.
Children from 6 to 14 years old: 10 - 20 drops of the drug EspumisanЃ baby 3-5 times a day.
Children from 14 and 18 years old: 20 drops of the drug EspumisanЃ baby 3-5 times a day.

In preparation for diagnostic tests (X-ray, ultrasound, etc.)
Apply 1 ml of the drug EspumisanЃ baby 3 times a day after meals the day before the study and 1 ml of the drug EspumisanЃ baby in the morning of the day of the study.

To obtain a double contrast image
Add 2-4 ml of the drug EspumisanЃ baby per 1 liter of contrast suspension.

In preparation for esophagogastroduodenoscopy
Inside, 2-3 ml of the drug EspumisanЃ baby before the study. During endoscopy, if necessary, a few milliliters of emulsion can be injected through the endoscope channel to eliminate gas bubbles that interfere with the examination.

In
case of acute poisoning with detergents containing tensides 1-4 ml of EspumisanЃ baby, depending on the severity of the poisoning.

1 ml (25 drops) of the drug contains:

Active ingredient: simethicone - 100.00 mg

Excipients: macrogol stearate 40 - 6.17 mg, glyceryl monostearate 40-55 - 3.78 mg, carbomer - 5.98 mg, banana flavor - 3.98 mg, potassium acesulfame - 0.30 mg, liquid sorbitol (non-crystallizing ) - 199.17 mg, sodium chloride - 0.67 mg, sodium citrate - 4.19 mg, sodium hydroxide - 0.67 mg, sorbic acid - 1.06 mg, purified water - 732.25 mg.

Hypersensitivity to the components of the drug, intestinal obstruction, hereditary fructose intolerance.

Registration number: RU LP-003044 dated 06/18/2015

Trade name of the drug: EspumisanЃ baby

International non-proprietary name: simethicone

Dosage form: drops for oral administration

Composition:

1 ml (25 drops) of the drug contains:

Active ingredient: simethicone - 100.00 mg

Excipients: macrogol stearate 40 - 6.17 mg, glyceryl monostearate 40-55 - 3.78 mg, carbomer - 5.98 mg, banana flavor - 3.98 mg, potassium acesulfame - 0.30 mg, liquid sorbitol (non-crystallizing ) - 199.17 mg, sodium chloride - 0.67 mg, sodium citrate - 4.19 mg, sodium hydroxide - 0.67 mg, sorbic acid - 1.06 mg, purified water - 732.25 mg.

Description: slightly viscous milky white emulsion with a banana scent.

Pharmacotherapeutic group: carminative.

ATX code: A03AX13

Pharmacological properties

Pharmacodynamics
The drug EspumisanЃ baby reduces the amount of gas in the gastrointestinal tract (GIT). The active substance - simethicone has surface-active properties and the ability to reduce surface tension at the liquid / gas interface, which promotes the fusion of gas bubbles and the destruction of foam in the intestine, as a result of which the released gas is absorbed or excreted naturally under the influence of intestinal motility. The use of simethicone in preparation for diagnostic examinations of the abdominal organs prevents the occurrence of image defects caused by gas bubbles.

Pharmacokinetics
Simethicone is chemically inert, after oral administration it is not absorbed from the gastrointestinal tract and acts only in its lumen. Does not interact with microorganisms and enzymes and does not affect digestion processes. It is excreted by the intestines unchanged.

Indications for use

- symptoms of intestinal colic in infants;

- symptoms of excessive formation and accumulation of gases in the gastrointestinal tract (including flatulence, increased gas production in the postoperative period);

- symptoms of excessive gas formation caused by functional dyspepsia;

- preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (ultrasound, radiography, esophagogastroduodenoscopy, etc.), including, as an additive to contrast media suspensions for obtaining images by the double contrast method;

- acute poisoning with detergents containing foaming agents (tensides) as an antifoam agent.

Contraindications

Hypersensitivity to the components of the drug, intestinal obstruction, hereditary fructose intolerance.

Application during pregnancy and during breastfeeding

The drug EspumisanЃ baby can be used during pregnancy and during breastfeeding.

Method of administration and dosage